Navigation Links
Omnicare Clinical Research Acquired by Nautic Partners, LLC
Date:4/28/2011

KING OF PRUSSIA, Pa., April 28, 2011 /PRNewswire/ -- Omnicare Clinical Research (CR), a leading global, full-service contract research organization (CRO), announced today that it has been acquired by Nautic Partners, LLC, a private equity firm based in Providence, R.I. The signing of the deal not only makes official the separation of Omnicare CR from former parent company, Omnicare, Inc., it achieves the company's most visible step in a comprehensive two-year plan to accelerate Omnicare CR into the future.

With over 25 years of quality service, Omnicare CR has established its own strategic business-unit model to best serve the most complex trials. Over the last five years, Omnicare CR has successfully completed over 1,500 studies worldwide with more than 337,000 participating patients. Now, as the CRO takes this next step forward, added support from Nautic will allow Omnicare CR to meet customer needs even more quickly.

"Our new affiliation with Nautic is very exciting for all of us at Omnicare CR. This marks a new era for our business that will provide us the ability to more efficiently make vital, strategic decisions, placing us in control of our own destiny," said Dr. James M. Pusey, president & CEO of Omnicare CR. "The group in the best position to benefit from this reorganization is our current and future customer base. With our renewed strength, Omnicare CR will be able to deliver an even higher level of customer service while maintaining the teams currently in place who support our customers on a day-to-day basis."

According to Pusey, the affiliation with Nautic was the best possible partnership for the company. "The interest in Omnicare CR has been intense and our new partnership with Nautic gives us the opportunity to further specialize our business model, invest in the company's future and grow our high-quality organization."

Nautic's managing director, Chris Crosby, led the deal with Omnicare CR'
'/>"/>

SOURCE Omnicare Clinical Research
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Stanford and SanBio Announce a Clinical Trial of Cell Therapy for Stroke Disability
2. ACT Files European Clinical Trial Application for Phase 1/2 Study Using Embryonic Stem Cells to Treat Macular Degeneration
3. Tissue Genesis Begins FDA-Approved Clinical Trial
4. ClearCanvas Releases First Commercial Version of Popular Clinical Radiology Workstation; PACS and RIS to Follow
5. Proteon Therapeutics Initiates Patient Enrollment in Phase 2 Clinical Study of PRT-201 in Hemodialysis Patients
6. S*BIO Initiates Phase 2 Clinical Trial of its Novel JAK2 Inhibitor SB1518 in North America for Advanced Lymphoid Malignancies
7. ePharmaSolutions Launches New Application to Streamline Single Sign-On and User Account Provisioning for Sponsors Using Multiple Clinical Trial Technologies
8. Neurocrine Biosciences Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor
9. Tolerx Presents Preclinical Data on Novel Anti-GITR Cancer Immunotherapeutic Demonstrating Enhanced Anti-Tumor Responses
10. Ridge Diagnostics, Inc. Clinical Data on Blood Test for Depression to be Presented at the American Psychiatric Association Annual Meeting
11. CryoLife Files Investigational Device Exemption (IDE) to Begin Clinical Trials for PerClot® in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: ... China,s leading provider of cord blood ... storage services, today announced that the Special Committee of the ... Houlihan Lokey ( China ) Limited as ... Hamilton LLP as its United States ...
(Date:6/2/2015)... June 2, 2015 MGB ... antibiotic resistance problem  MGB Biopharma, a ... anti-infectives, to address the major global problem of ... a stable intravenous (IV) formulation of MGB-BP-3, designed for ... infections.  The intravenous formulation of MGB-BP-3 ...
(Date:6/1/2015)... , June 1, 2015  Turing Pharmaceuticals ... Eliseo Oreste Salinas , MD, MSc,  has joined ... Dr. Salinas, who holds a medical ... brings a record of significant accomplishments in the ... Dr. Salinas has played a leadership ...
(Date:6/1/2015)... CHICAGO , June 1, 2015 /PRNewswire/ ... robust Decipher® genomic analysis platform, successfully classified ... the genomic expression of certain biomarkers, including ... chemotherapy. Importantly, this unique genomic signature has ... responsiveness to neoadjuvant chemotherapy in patients with ...
Breaking Biology Technology:China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 3MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 2MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 3Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 4
... article, the City of Milwaukee has negotiated a three-year "franchise-like" ... company to start an Internet protocol video service to compete ... will be considered by the Milwaukee Common Council, AT&T would ... by the service. , , While there are ...
... big business (untold billions of dollars every year), they also ... of the fundamental ethical principle of informed consent ... is that conducting a clinical trial carries with it the ... positive or negative or even if the clinical trial is ...
... For the second time this year, a tech-based company in ... to the public. Called an initial public offering, this kind ... and investors who are directly involved, but to others who ... Madison-based biotechnology company, has filed papers with the Securities ...
Cached Biology Technology:State video franchises vs. universal service: Grasping the total picture 2State video franchises vs. universal service: Grasping the total picture 3State video franchises vs. universal service: Grasping the total picture 4What patients want: A story of choice, clinical trials & evidence-based medicine 2What patients want: A story of choice, clinical trials & evidence-based medicine 3What patients want: A story of choice, clinical trials & evidence-based medicine 4What patients want: A story of choice, clinical trials & evidence-based medicine 5Wisconsin IPOs are a harbinger of growing tech economy 2Wisconsin IPOs are a harbinger of growing tech economy 3
(Date:5/19/2015)... 18, 2015 Fingerprint Cards (FPC) has ... FPC1145, FPC1155 and FPC1035 from one if its module partners. ... including Q3 2015 and the sensors will be used by ... values for 2015 hereby amount to 740 MSEK to date. ... 140 MSEK and a number of smaller orders not separately ...
(Date:5/19/2015)... 19, 2015 Research ... addition of the  "Genetic Testing Market Outlook ... http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic Testing ... of the current and future genetic testing ... their working principles and types are covered ...
(Date:5/14/2015)... and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ) has announced ... Smart Mobile Devices " report to their offering. ... watershed year for fingerprint sensors in smartphones and tablets, ... fingerprint sensors a raison d,etre in the mobile milieu ... must-have feature in flagship smartphones. The key ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Global Genetic Testing Market Outlook 2018 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2
... To develop correctly, baby hearts need rhythm...even before they ... mechanical forces are important when making baby hearts," said ... a team of Vanderbilt engineers, scientists and clinicians attempting ... cells. In an article published last month in ...
... of engineers from universities in the U.S., Canada, and Qatar ... damage on bridges, stadiums and other large public infrastructure. ... government of Qatar, a Persian Gulf nation that has proposed ... three-member team is developing a wireless sensor network that will ...
... at The Wistar Institute have developed a mathematical method ... type of brain cancer, through variations in the way ... capable of predicting the subclasses of glioblastoma tumors ... could enable physicians to accurately predict which forms of ...
Cached Biology News:Baby hearts need rhythm to develop correctly 2Baby hearts need rhythm to develop correctly 3Baby hearts need rhythm to develop correctly 4Novel sensor system would flag structural weaknesses before bridges and stadiums collapse 2Wistar scientists develop gene test to accurately classify brain tumors 2Wistar scientists develop gene test to accurately classify brain tumors 3
... Collect eliminates manual data entry by collecting ... any Windows-based application. Collect is extremely ... hours of tedious data entry. An ... scales, pH meters, spectrophotometers, force gauges, digital ...
Mouse monoclonal [5H9] to RAD52 ( Abpromise for all tested applications). entrezGeneID: 5893 SwissProtID: P43351...
Purified anti-LAT...
Cytosol/Particulate Rapid Separation Kit Research Focus: other Storage Temperature: -20C Shipping Temperature: 4C...
Biology Products: